Based on the pivotal role of HIF-1 in cancer metastasis, strategies targeting HIF-1α dimerization are identified as potential cancer therapeutics, although none have been successfully developed into clinically approved treatments yet (Bui et al., 2022). This evidence concerns the gene HIF1A and cancer.